The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
bendamustine hydrochloride
bendamustine hydrochloride · BENDAMUSTINE HYDROCHLORIDE 100 mg/20mL · Injection, Powder, Lyophilized, For Solution · Intravenous · BluePoint Laboratories
NDC 68001-0572-41 · 1 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$1,600.00
Reported to Texas DSHS · 2026 annual filing · Blue Point Laboratories
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 1 MG
$2.960
HCPCS J9033 · Jul 1, 2026 quarter · typically ASP + 6%
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA205574
- TE code
- AP
- Approval date
- Dec 7, 2022
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Treanda, Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton (NDC 63459-390-08)Jul 23, 2026
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of bendamustine hydrochloride (Injection, Powder, Lyophilized, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Accord Healthcare, Inc. | BENDAMUSTINE HYDROCHLORIDE 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Accord Healthcare, Inc. | BENDAMUSTINE HYDROCHLORIDE 25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| BluePoint Laboratories | BENDAMUSTINE HYDROCHLORIDE 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Cephalon, LLC | BENDAMUSTINE HYDROCHLORIDE 25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Cephalon, LLC | BENDAMUSTINE HYDROCHLORIDE 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | BENDAMUSTINE HYDROCHLORIDE 100 mg/20mL | Jul 15, 2026 | Sep 2, 2026 |
| Eugia US LLC | BENDAMUSTINE HYDROCHLORIDE 25 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "bendamustine hydrochloride — NDC 68001-0572-41," retrieved September 3, 2026, https://drugdashboards.com/drug/68001057241.
Free to cite with attribution — see how the data is put together.